cros and clinical trials: strategic partnerships driving future growth

Post on 20-Aug-2015

3.708 Views

Category:

Health & Medicine

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

CROs & Clinical Trials:Strategic Partnerships Driving

Future Growth?

December 14th, 2010

2N16C-52

Agenda

• CRO Market Overview

• 2009-2010 Performance Review

• Tactical vs. Strategic Outsourcing

• Review of Major Strategic Deals

3N16C-52

What do CROs offer?

4N16C-52

Factors Affecting Market Growth

CONTRACT RESEARCH ORGANIZATIONS MARKET (2010-2017)

Shift Toward Strategic Outsourcing

Pressure to Lower Fixed Costs

Improving R&D Efficiency and Quality

Demand for Global Trials

Stringent Regulatory EnvironmentRising R&D Cost

Pressure to Improve Clinical Pipeline

Integration of Pharma and Biotech Commoditization of Services

5N16C-52

CRO Market Structure

6N16C-52

Review of 2009-2010 CRO Performance

Top 6 Publicly Traded CROs: Covance, Charles River, ICON, Kendle, Parexel and PPD

7N16C-52

Tactical vs Strategic Outsourcing

• Project-by-project focus • Integrated program outsourcing throughout lifecycle

• Competitive bidding • Funnel a large percentage of work to a few strategic partners

• Inconsistent monitoring • CRO performance monitored and tracked by internal benchmarks

• Superior-subordinate relationship

• Well-defined governance structure

8N16C-52

Types of Outsourcing Relationships

9

Review of Major Strategic Deals

10N16C-52

Covance – Eli Lilly (2008)

11N16C-52

PPD – Merck (2009)

12N16C-52

Covance – Sanofi Aventis (2010)

13N16C-52

Review of Deals

Win-WinWin-Win

14N16C-52

Key Strategic Objectives

15N16C-52

CRAMsCRAMs

CROsCROs Drug ManufacturersDrug Manufacturers

Contract Research and Manufacturing Contract Research and Manufacturing OrganizationsOrganizations

Emerging Hybrid Business ModelEmerging Hybrid Business Model

• Global scale ─ ability to run clinical trials across global regions

• eClinical capabilities for clinical trial management

• Access to patient pools

• Global scale ─ ability to run clinical trials across global regions

• eClinical capabilities for clinical trial management

• Access to patient pools

• Scalability of drug manufacturing from clinical trials to commercialization

• Reduces fixed costs for pharmaceutical industry

• Access to proprietary drug delivery platforms

• Scalability of drug manufacturing from clinical trials to commercialization

• Reduces fixed costs for pharmaceutical industry

• Access to proprietary drug delivery platforms

Contract Services Employing Hybrid Business Models

Source: Frost & SullivanSource: Frost & Sullivan

16

Questions?

17N16C-52

Next Steps

Request a proposal for or Growth Partnership Services or Growth Consulting Services to

support you and your team to accelerate the growth of your company. (myfrost@frost.com) 1-

877-GoFrost (1-877-463-7678)

Join us at our annual Growth, Innovation, and Leadership 2011: A Frost & Sullivan Global

Congress on Corporate Growth (www.gil-global.com)

Register for the next Chairman’s Series on Growth: Driving Innovation – The What, Why, and

How. Visions and Benchmarks as the Innovation Key

(October 5th) (http://www.frost.com/growth)

Register for Frost & Sullivan’s Growth Opportunity Newsletter and keep abreast of innovative

growth opportunities

(www.frost.com/news)

18N16C-52

Your Feedback is Important to Us

Growth Forecasts?

Competitive Structure?

Emerging Trends?

Strategic Recommendations?

Other?Please inform us by taking our survey.

What would you like to see from Frost & Sullivan?

Frost & Sullivan’s Growth Consulting can assist with your growth strategies

19N16C-52

http://twitter.com/frost_sullivan

Follow Frost & Sullivan on Facebook, LinkedIn, SlideShare, and Twitter

http://www.facebook.com/FrostandSullivan

http://www.linkedin.com/companies/4506

http://www.slideshare.net/FrostandSullivan

20N16C-52

For Additional Information

NameCorporate CommunicationsIndustry(210) XXX-XXXXEmail@frost.com

NameSales ManagerIndustry(XXX) XXX-XXXXemail@frost.com

Jennifer BriceIndustry ManagerPharmaceuticals & Biotechnology(650) 475-4560Jennifer.brice@frost.com

NameSales ManagerIndustry(XXX) XXX-XXXXemail@frost.com

top related